Better Buy: Veeva Systems vs. Cerner
Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) offer investors some unique opportunities to invest not only in healthcare but in technology as well. These two stocks can give investors the best of both worlds -- growth and stability. But deciding between the two is no easy task, as investors will need to determine just how much growth they're looking for versus how much stability they require.
Veeva's stock has skyrocketed over the past five years, rising a whopping 400%, well in excess of the 62% returns that the S&P 500 has generated during that time. The cloud-software company works in healthcare, but Veeva isn't your typical healthcare stock. With significant technical capabilities, the company is tech giant salesforce.com's "preferred worldwide partner for the pharmaceutical and biotech industry." The two companies have a partnership that extends into 2025, allowing Veeva to develop unique applications for the healthcare industry.
One of the applications that Veeva has developed with Salesforce is a customer relationship management (CRM) application designed with care providers in mind. Currently, more than 50 biopharmaceutical companies around the world use the software. It's a great growth opportunity for Veeva to reach even more healthcare providers, especially those that may not be all that familiar with CRM.
Source Fool.com
